Based on the Solventum Corp. stock forecast from 6 analysts, the average analyst target price for Solventum Corp. is USD 77.56 over the next 12 months. Solventum Corp.’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Solventum Corp. is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, Solventum Corp.’s stock price was USD 70.23. Solventum Corp.’s stock price has changed by +3.86% over the past week, +6.10% over the past month and +10.18% over the last year.
No recent analyst target price found for Solventum Corp.
No recent average analyst rating found for Solventum Corp.
Company Overview Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota. Read Less
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Sy...Read More
Frequently Asked Questions About Solventum Corp. (SOLV) Stock
Based on ratings from 6 analysts Solventum Corp.'s stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has buy, 1 sell and 8 hold ratings.
Unfortunately we do not have enough data on SOLV's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SOLV is USD 77.56 over the next 12 months. The maximum analyst target price is USD 85 while the minimum anlayst target price is USD 70.
SOLV stock's Price/Earning ratio is 23.99.
Our analysis grades SOLV stock's Price / Earning ratio at B. This means that SOLV stock's Price/Earning ratio is above 17% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this SOLV may be undervalued for its sector.
The last closing price of SOLV's stock was USD 70.23.
The most recent market capitalization for SOLV is USD 11.45B.
Based on targets from 6 analysts, the average taret price for SOLV is projected at USD 77.56 over the next 12 months.
This means that SOLV's stock price may go up by +10.43% over the next 12 months.
We can't find any ETFs which contains Solventum Corp.'s stock.
As per our most recent records Solventum Corp. has 22,000 Employees.
Solventum Corp.'s registered address is 3M Center, Maplewood, MN, United States, 55144-1000.
You can get more information about it from Solventum Corp.'s website at https://www.solventum.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Solventum Corp. (SOLV) Stock
Based on ratings from 6 analysts Solventum Corp.'s stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has buy, 1 sell and 8 hold ratings.
Unfortunately we do not have enough data on SOLV's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SOLV is USD 77.56 over the next 12 months. The maximum analyst target price is USD 85 while the minimum anlayst target price is USD 70.
SOLV stock's Price/Earning ratio is 23.99.
Our analysis grades SOLV stock's Price / Earning ratio at B. This means that SOLV stock's Price/Earning ratio is above 17% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this SOLV may be undervalued for its sector.
The last closing price of SOLV's stock was USD 70.23.
The most recent market capitalization for SOLV is USD 11.45B.
Based on targets from 6 analysts, the average taret price for SOLV is projected at USD 77.56 over the next 12 months.
This means that SOLV's stock price may go up by +10.43% over the next 12 months.
We can't find any ETFs which contains Solventum Corp.'s stock.
As per our most recent records Solventum Corp. has 22,000 Employees.
Solventum Corp.'s registered address is 3M Center, Maplewood, MN, United States, 55144-1000.
You can get more information about it from Solventum Corp.'s website at https://www.solventum.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SOLV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
